Phase II study of cisplatin and imatinib in advanced salivary adenoid cystic carcinoma

British Journal of Oral and Maxillofacial Surgery

Volumn 49, Issue 7, 2011, Pages 510-515

  Ghosal, Niladri ^a   Mais, Kathleen ^b   Shenjere, Patrick ^b   Julyan, P ^b   Hastings, D ^b   Ward, T ^b   Ryder, W D ^b   Bruce, Iain ^c   Homer, J ^b   Slevin, N J ^b  

^a GLAN CLWYD HOSPITAL   (United Kingdom)

^b CHRISTIE HOSPITAL   (United Kingdom)

^c MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Adenoid cystic carcinoma; Cisplatin; FDG PET scan; Imatinib

Indexed keywords

CISPLATIN; FLUORODEOXYGLUCOSE; IMATINIB; TYROSINE KINASE RECEPTOR;

ADENOID CYSTIC CARCINOMA; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER GROWTH; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL; POSITRON EMISSION TOMOGRAPHY; SALIVARY GLAND CARCINOMA; THORAX RADIOGRAPHY;

ADULT; AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, ADENOID CYSTIC; CISPLATIN; DISEASE PROGRESSION; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PIPERAZINES; POSITRON-EMISSION TOMOGRAPHY; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS C-KIT; PYRIMIDINES; RADIOGRAPHY, THORACIC; RADIOPHARMACEUTICALS; REMISSION INDUCTION; SALIVARY GLAND NEOPLASMS; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 80052965803     PISSN: 02664356     EISSN: 15321940     Source Type: Journal    
DOI: 10.1016/j.bjoms.2010.09.013     Document Type: Article

References (23)

1. J.G. Azzopardi, and O.D. Smith Salivary gland tumours and their mucins J Pathol Bacteriol 77 1959 131 140
2. A.S. Jones, J.W. Hamilton, H. Rowley, D. Husband, and T.R. Helliwell Adenoid cystic carcinoma of the head and neck Clin Otolaryngol Allied Sci 22 1997 434 443 (Pubitemid 28344903)
3. R.L. Dodd, and N.J. Slevin Salivary gland adenoid cystic carcinoma: a review of chemotherapy and molecular therapies Oral Oncol 42 2006 759 769 (Pubitemid 44307768)
4. A.G. Renehan, E.N. Gleave, N.J. Slevin, and M. McGurk Clinico-pathological and treatment-related factors influencing survival in parotid cancer Br J Cancer 80 1999 1296 1300 (Pubitemid 29264095)
5. R.H. Spiro Distant metastasis in adenoid cystic carcinoma of salivary origin Am J Surg 174 1997 495 498 (Pubitemid 127738601)
6. J. Fordice, C. Kershaw, A. El-Naggar, and H. Goepfert Adenoid cystic carcinoma of the head and neck: predictors of morbidity and mortality Arch Otolaryngol Head Neck Surg 125 1999 149 152 (Pubitemid 29085262)
7. P.M. Stell Adenoid cystic carcinoma Clin Otolaryngol Allied Sci 11 1986 267 291 (Pubitemid 17188474)
8. R.H. Spiro, A.G. Huvos, and E.W. Strong Adenoid cystic carcinoma: factors influencing survival Am J Surg 138 1979 579 583 (Pubitemid 10250075)
9. L.S. Eby, D.S. Johnson, and H.W. Baker Adenoid cystic carcinoma of the head and neck Cancer 29 1972 1160 1168
10. V.L. Schramm Jr., C. Srodes, and E.N. Myers Cisplatin therapy for adenoid cystic carcinoma Arch Otolaryngol 107 1981 739 741 (Pubitemid 12245992)
11. I.F. Tannock, and D.J. Sutherland Chemotherapy for adenocystic carcinoma Cancer 46 1980 452 454 (Pubitemid 10036634)
12. J.B. Vermorken, J. Verweij, P.H. de Mulder, F. Cognetti, M. Clavel, and S. Rodenhuis Epirubicin in patients with advanced or recurrent adenoid cystic carcinoma of the head and neck: a phase II study of the EORTC Head and Neck Cancer Cooperative Group Ann Oncol 4 1993 785 788 (Pubitemid 23340091)
13. M.E. Hill, D.O. Constenla, R.P. A'Hern, J.M. Henk, P. Rhys-Evans, and N. Breach Cisplatin and 5-fluorouracil for symptom control in advanced salivary adenoid cystic carcinoma Oral Oncol 33 1997 275 278
14. L. Licitra, R. Cavina, C. Grandi, S.D. Palma, M. Guzzo, and R. Demicheli Cisplatin, doxorubicin and cyclophosphamide in advanced salivary gland carcinoma. A phase II trial of 22 patients Ann Oncol 7 1996 640 642 (Pubitemid 26285647)
15. E.T. Creagan, J.E. Woods, J. Rubin, and D.J. Schaid Cisplatin-based chemotherapy for neoplasms arising from salivary glands and contiguous structures in the head and neck Cancer 62 1988 2313 2319
16. V.A. Holst, C.E. Marshall, C.A. Moskaluk, and H.F. Frierson Jr. KIT protein expression and analysis of c-kit gene mutation in adenoid cystic carcinoma Mod Pathol 12 1999 956 960 (Pubitemid 29485269)
17. Y.M. Jeng, C.Y. Lin, and H.C. Hsu Expression of the c-kit protein is associated with certain subtypes of salivary gland carcinoma Cancer Lett 154 2000 107 111
18. S.J. Hotte, E.W. Winquist, E. Lamont, M. MacKenzie, E. Vokes, and E.X. Chen Imatinib mesylate in patients with adenoid cystic cancers of the salivary glands expressing c-kit: a Princess Margaret Hospital phase II consortium study J Clin Oncol 23 2005 585 590 (Pubitemid 46224236)
19. M.R. Pfeffer, Y. Talmi, R. Catane, Z. Symon, A. Yosepovitch, and M. Levitt A phase II study of Imatinib for advanced adenoid cystic carcinoma of head and neck salivary glands Oral Oncol 43 2007 33 36 (Pubitemid 46162246)
20. I.A. Bruce, N.J. Slevin, J.J. Homer, A.T. McGown, and T.H. Ward Synergistic effects of imatinib (STI 571) in combination with chemotherapeutic drugs in head and neck cancer Anticancer Drugs 16 2005 719 726 (Pubitemid 41104920)
21. S. Faivre, E. Raymond, O. Casiraghi, S. Temam, and P. Berthaud Imatinib mesylate can induce objective response in progressing, highly expressing KIT adenoid cystic carcinoma of the salivary glands J Clin Oncol 23 2005 6271 6273 author reply 6273-4
22. J.C. Alcedo, J.M. Fábrega, J.R. Arosemena, and A. Urrutia Imatinib mesylate as treatment for adenoid cystic carcinoma of the salivary glands: report of two successfully treated cases Head Neck 26 2004 829 831 (Pubitemid 39159307)
23. L. Vila, H. Liu, S.Z. Al-Quran, D.P. Coco, H.J. Dong, and C. Liu Identification of c-kit gene mutations in primary adenoid cystic carcinoma of the salivary gland Mod Pathol 22 2009 1296 1302